Effect of EECP on Anterior Ischemic Optic Neuropathy

First Affiliated Hospital, Sun Yat-Sen University40 enrolled

Overview

Enhanced External Counterpulsation(EECP) therapy may promote the recovery of visual function by improving the blood perfusion of eyes. The present study aims to investigate the effect of EECP on Anterior Ischemic Optic Neuropathy.

Patients with Anterior Ischemic Optic Neuropathy are randomized into two groups: one group receive standard medical treatment for ischemic optic neuropathy, the other group plus EECP therapy besides standard medical treatment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Anterior Ischemic Optic Neuropathy

Interventions

Enhanced external counterpulsationDEVICE

EECP is performed for 1 hours every day, for a total of 36 hours.

AspirinDRUG

Standard drug therapy

Eligibility

Sex: ALLMin age: 40 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * ischemic optic neuropathy * within 1 month Exclusion Criteria: * Hemorrhagic disease * thrombophlebitis or infection lesions * severe hypertensive patients * Atrial fibrillation * Aortic regurgitation

Locations (1)

The First Affiliated Hospital of Sun Yat- sen University

Guangzhou, Guangdong, China

RECRUITING

Outcomes

Primary Outcomes

visual acuity

Time frame: 7 weeks

Secondary Outcomes

Ophthalmic artery blood flow velocity

Time frame: 7 weeks

Central Contacts

Yan Zhang, MD

CONTACT

862087755766 Zhyan3@mail.sysu.edu.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.